bioengineering

Applications are no longer being accepted The application period for this position has ended. Adjunct Principal Investigator positions for experts in Pain/Nociception Research (all genders) CeMM, Vienna is...

TU-ID: 163 | 2026 | 42 | 272941 Assistant Professorship (all genders) - Tenure Track "Protein Engineering (CoE CircBioeng)“ TU Wien is Austria's largest institution of research and higher education in the fields of technology and natural sciences. With over 26,000 students and more than 4000 scientists, research, teaching, and learning dedicated to the...

Stellen-ID: 64267 Standort: Wien, AUT Karrierestufe: Einsteiger Fachbereich: Forschung und Entwicklung Beschäftigungstyp: Befristete Anstellung Werden Sie Teil einer lebenswichtigen Kette und tragen Sie zu unserem gemeinsamen Ziel bei, das Leben von Menschen zu verbessern. Octapharma ist ein führendes biopharmazeutisches Unternehmen, das die Stärke...

Werden Sie Teil einer lebenswichtigen Kette und tragen Sie zu unserem gemeinsamen Ziel bei, das Leben von Menschen zu verbessern. Octapharma ist ein führendes biopharmazeutisches Unternehmen, das die Stärke einer globalen Organisation mit den Werten eines Familienunternehmens vereint. Wir sind auf die Entwicklung und Herstellung hochwertiger Arzneimittel...

The group you’ll be a part of   The Global Operations Group brings information systems, facilities, supply chain, logistics, and high-volume manufacturing together to drive the engine of our global business operations. We help Lam deliver industry-leading solutions with speed and efficiency, while actively supporting the resilient and profitable...

The MissionDrug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment.Our platform is 87% concordant with clinical patient data - a vast improvement over the...

The MissionDrug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment.Our platform is 87% concordant with clinical patient data - a vast improvement over the...

The Mission Drug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment. Our platform is 87% concordant with clinical patient data - a vast improvement over...